New Kids on the Block: Introducing Immunotherapy for Hematologic Malignancies
New Kids on the Block: Introducing Immunotherapy for Hematologic Malignancies
Contact: Kellie Antinori-Lent, antikj@upmc.edu
Target Audience
Nurse
DNP
CNS
Learning Objectives
Identify one physiologic and clinical feature of a hematological malignancy.
List one treatment option for each of the various hematological malignancies discussed.
Additional Information
Attachment | Size |
---|---|
Flyer June 14th Program Rearick.docx | 1.27 MB |
New immunological therapies available for treating cancer are not well understood by non-oncology nurses. There are several different immunological therapies available for patients with hematological cancers.
This presentation will improve awareness and understanding of the new treatments on the market for treating blood cancers.
Kellie Antinori-Lent, MSN, RN, CNS, ACNS-BC, BC-ADM, CDCES, FADCES
Markie Rearick, MSN, RN, BMTCN
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nursing (CNE)
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour(s).
The maximum number of pharmacology hours awarded for this Continuing Nursing Education activity is 0.5 contact hour(s).
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Available Credit
- 1.00 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 0.50 Pharmacotherapeutic
- 1.00 Attendance